Search

NB Science M3 Mutant Peptide Patent for Myopathy, Obesity, Diabetes

USPTO granted patent US12605431B2 to NB SCIENCE CO., LTD. on April 21, 2026. The patent covers an M3 mutant peptide composition for treating or preventing myopathy, obesity, or diabetes, listing five claims under CPC classifications including A61K 38/4886 and A61P 3/04. The application (18267252) was filed on December 14, 2021.